We asked 10,000 transplant recipients about their experience with immunosuppressants.
Check out this Journal Club, now on YouTube, to learn about the findings.
https://t.co/y76gF05Xnr
📣 New insight on long-term outcomes after Fontan conversion!
A recent study in Circulation: Heart Failure explores the long-term results of Fontan conversion surgery (FC) — a procedure aimed at improving circulation and reducing complications in patients with failing Fontan physiology.
🫀 Key takeaways:
• Fontan conversion is known to lower the risk of atrial arrhythmias and thromboembolism, but its impact on long-term survival had been unclear.
• This comparative analysis provides real-world evidence on outcomes over time in patients undergoing FC — addressing a major clinical gap in the care of adults with congenital heart disease.
📌 Why it matters:
Improving survival and reducing complications after Fontan conversion can help guide decision-making and long-term management in a complex, high-risk patient population.
#Fontan #CongenitalHeartDisease #HeartFailure
#Cardiology #CirculationHeartFailure #CardioResearch
#LongTermOutcomes 🫀📊
https://t.co/R6mLQTLyCv
Please save the date:
35th Annual International Symposium on Adult Congenital Heart Disease
Cincinnati Ohio, June 3-6
@ACHDSymposium@TorontoACHD
https://t.co/uM2B4mjcAd
Honored to lead and contribute to the future of multidisciplinary transplant care @ClevelandClinic — to become the world’s most comprehensive, innovative, and premier transplant enterprise for patients with end-stage organ failure.
https://t.co/ExaThGNE5O
If you’re noticing muscle loss while losing weight on a GLP-1, you can take matters into your own hands by focusing on your protein intake, staying hydrated and starting a strength training program. https://t.co/OyQLqVKvt1
@Buckingham_Show I’m so sorry to hear this! My heart was falling last year and my liver. I received a heart and liver transplant last year. Do they think you are a candidate for at least two of the organs?
A first in man, ischemia-free beating heart transplantation (IFBHT) in humans was described! This involves transplanting a heart without the typical interruption of blood flow (ischemia).
See below the video and article in Lancet !